000			01819cam a2200445 i 4500
003			OSt
005			20221019073103.0
020			_a9780128161210 _qpaperback
020			_a0128161213 _qpaperback
040			_aNLM _beng _cNLM _erda _dBDX _dYDXIT _dOCLCF _dYDX _dOCLCO _dOCLCQ _dOCLCA _dOCLCQ _dOCLCA _dAU@ _dDLC
041			_aEng
042			_apcc
050	0	0	_aR853.B54 _bH35 2019
060	0	0	_a2019 G-253
060	1	0	_aQV 745
100	1		_aHalim, Abdel B., _eauthor.
245	1	0	_aBiomarkers, diagnostics, and precision medicine in the drug industry : _bcritical challenges, limitations, and roadmaps for the best practices / _cAbdel B. Halim.
264		1	_aLondon, United Kingdom ; _aSan Diego, CA : _bAcademic Press, _c[2019]
300			_axii, 282 pages : _billustrations ; _c28 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
650		0	_aBiochemical markers.
650		0	_aPersonalized medicine.
650		0	_aPharmaceutical industry.
650	1	2	_aDrug Discovery.
650	1	2	_aBiomarkers.
650	2	2	_aDrug Development.
650	2	2	_aPrecision Medicine.
650	2	2	_aDiagnostic Techniques and Procedures.
650	2	2	_aClinical Laboratory Techniques.
650		7	_aBiochemical markers. _0(OCoLC)fst00831950
650		7	_aPersonalized medicine. _0(OCoLC)fst01910010
650		7	_aPharmaceutical industry. _0(OCoLC)fst01060129
856	4	1	_uhttps://ebookcentral.proquest.com/lib/qut/detail.action?docID=5788824 _zProQuest Ebook Central
906			_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg
942			_2lcc _cBK
999			_c3554 _d3554